Correlation Between H B and BioNexus Gene

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both H B and BioNexus Gene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining H B and BioNexus Gene into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between H B Fuller and BioNexus Gene Lab, you can compare the effects of market volatilities on H B and BioNexus Gene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in H B with a short position of BioNexus Gene. Check out your portfolio center. Please also check ongoing floating volatility patterns of H B and BioNexus Gene.

Diversification Opportunities for H B and BioNexus Gene

0.68
  Correlation Coefficient

Poor diversification

The 3 months correlation between FUL and BioNexus is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding H B Fuller and BioNexus Gene Lab in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioNexus Gene Lab and H B is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on H B Fuller are associated (or correlated) with BioNexus Gene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioNexus Gene Lab has no effect on the direction of H B i.e., H B and BioNexus Gene go up and down completely randomly.

Pair Corralation between H B and BioNexus Gene

Considering the 90-day investment horizon H B Fuller is expected to generate 0.48 times more return on investment than BioNexus Gene. However, H B Fuller is 2.08 times less risky than BioNexus Gene. It trades about 0.1 of its potential returns per unit of risk. BioNexus Gene Lab is currently generating about -0.48 per unit of risk. If you would invest  7,534  in H B Fuller on August 28, 2024 and sell it today you would earn a total of  265.00  from holding H B Fuller or generate 3.52% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

H B Fuller  vs.  BioNexus Gene Lab

 Performance 
       Timeline  
H B Fuller 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days H B Fuller has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, H B is not utilizing all of its potentials. The current stock price mess, may contribute to short-term losses for the institutional investors.
BioNexus Gene Lab 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BioNexus Gene Lab has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's essential indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

H B and BioNexus Gene Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with H B and BioNexus Gene

The main advantage of trading using opposite H B and BioNexus Gene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if H B position performs unexpectedly, BioNexus Gene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioNexus Gene will offset losses from the drop in BioNexus Gene's long position.
The idea behind H B Fuller and BioNexus Gene Lab pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Complementary Tools

Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA